Clinically proven Semaglutide therapy. Personalized Indian diet plans. Delivered to your doorstep.
India ranks among the world's most affected nations. The data is alarming — and worsening every year.
Zone-wise obesity rates across India. Source: Annals of Neurosciences, PMC10611613
Rising obesity rates among Indian adults (18-49 years). Source: PMC10611613
State-wise overweight/obesity prevalence (%). Source: NFHS-5 Data, PMC10611613
India faces a dual burden of malnutrition and rising obesity — necessitating evidence-based clinical interventions. ICMR-NIN 2024 Guidelines
Glucagon-like peptide-1 is a natural incretin hormone produced in your gut. It signals your brain to reduce appetite, slows stomach emptying, and regulates insulin secretion — your body's built-in weight management system.
Semaglutide mimics natural GLP-1 with a longer half-life. A weekly injection suppresses appetite, reduces caloric intake by ~30%, and delivers sustained weight loss of 15-17% body weight over 68 weeks.
The STEP trial program (1,961+ patients across 6 major trials) demonstrated unprecedented weight loss outcomes. Published in JAMA and Nature Medicine with rigorous peer review.
Weight loss (%) across STEP clinical trial program. Source: JAMA, Nature Medicine
Weight loss efficacy across anti-obesity medications. Source: JAMA Internal Medicine, DOI: 10.1001/jamainternmed.2024.2525
Semaglutide cardiovascular outcomes (SELECT Trial). Source: European Heart Journal, PMC11015952
Indian consensus recommends lower BMI cutoffs due to higher adiposity at lower BMI levels. Source: Indian Heart Journal, PMC5903015
Asian Indians have greater adiposity and higher comorbidity risks at lower BMI — using WHO cutoffs underestimates obesity in the Indian population.
Based on STEP 1 clinical trial data. Source: PMC9067867
5-minute clinically validated questionnaire covering your medical history, lifestyle, and goals.
Secure Razorpay payment via UPI, Cards, or NetBanking. One-time consultation fee.
Dr. Akhileshwar Reddy personally reviews your medical information and digitally signs your plan.
Custom weight loss protocol + Indian diet plan based on ICMR medical guidelines.
GLP-1 medication + supplements shipped pan-India to your doorstep.
Monthly check-ins, dose adjustments, and WhatsApp support throughout your journey.
GLP-1 Medication: ₹2,200–₹4,200/month (dose-dependent) — billed separately
STRICTLY NO REFUND POLICY — All payments are final. No refunds or cancellations.
Complete this clinically validated questionnaire to begin your transformation journey.
84.6% achieved ≥5% weight loss vs 31.5% placebo. N=1,961, 68 weeks.
-9.6% weight loss in patients with Type 2 Diabetes. N=1,210, 68 weeks.
-16.0% weight loss with intensive behavioral therapy. N=611, 68 weeks.
-17.4% weight loss sustained; +6.9% regain on placebo switch. N=902.
-15.2% sustained weight loss over 104 weeks — the longest STEP trial.
Semaglutide -15.8% vs Liraglutide -6.4%. Direct comparison. N=338.
Tirzepatide 76% more likely to achieve ≥5% loss vs semaglutide.
20% MACE reduction, 35% stroke reduction with semaglutide.
Cardiovascular benefits independent of HbA1c and glycemic status.
40.3% adults overweight/obese. 135M affected. Zone-wise and state-wise data.
Lower BMI cutoffs for Indian population: Overweight ≥23, Obese ≥25.
Updated 2024 guidelines: My Plate concept, 8 food groups, addressing dual burden of malnutrition.
India: 41M overweight children, 14M obese children by 2025. #2 globally.
Dal, roti, sabzi focused plan. Emphasizes whole wheat, seasonal vegetables, and controlled portions of paneer and ghee.
Rice, sambar, rasam optimized. Portion-controlled rice with generous sambar, rasam, and coconut-based vegetables.
Fish, mustard, leafy green balanced. Rich in omega-3 from fish, mustard oil, and seasonal greens like shak.
Dhokla, thepla, controlled portions. High-fiber, low-oil preparations with emphasis on steamed and fermented foods.
Preserve lean muscle during weight loss. 25g protein per serving.
Essential micronutrients to prevent deficiencies during caloric deficit.
High-potency EPA/DHA for cardiovascular and brain health support.
Psyllium-based fiber for digestive health and satiety during GLP-1 therapy.
Support skin elasticity and joint health during rapid weight loss.
Gut health support with 50B CFU multi-strain formula.
Glucagon-like peptide-1 (GLP-1) is an incretin hormone naturally produced by L-cells in your small intestine after eating. It plays a crucial role in glucose metabolism and appetite regulation.
When you eat, GLP-1 is released and acts on multiple organ systems: it stimulates insulin secretion from the pancreas, suppresses glucagon release, slows gastric emptying, and — critically — signals the hypothalamus in your brain to reduce appetite.
In people with obesity, this natural GLP-1 response is often blunted. Semaglutide, a GLP-1 receptor agonist, mimics and amplifies this natural hormone's effects with a weekly injection that maintains therapeutic levels throughout the week.
The result? Patients experience significantly reduced hunger, eat fewer calories naturally (studies show ~30% reduction in caloric intake), and achieve sustained weight loss that was previously only possible with bariatric surgery.
One of the biggest challenges with Western-centric weight loss programs is their incompatibility with Indian dietary habits. At India Fat to Fit, every diet plan is designed around your regional cuisine preferences.
Following the ICMR-NIN 2024 "My Plate" guidelines, we create balanced meal plans that include adequate cereals, pulses, vegetables, fruits, and dairy — all within a caloric deficit that complements GLP-1 therapy.
Key principles: Prioritize protein at every meal (dal, paneer, eggs, fish, chicken). Reduce refined carbs but don't eliminate them — swap white rice for hand-pounded rice or millets. Use healthy fats like mustard oil, coconut oil, and ghee in moderation. Increase fiber through vegetables, whole grains, and fruits.
Our doctors and nutritionists work together to ensure your diet plan maximizes the appetite-suppressing effects of semaglutide while preventing nutritional deficiencies common during rapid weight loss.
Like all medications, GLP-1 receptor agonists can cause side effects — most are mild, gastrointestinal, and resolve within 2-4 weeks as your body adjusts.
Common (10-20% of patients): Nausea (most common, usually mild), diarrhea, constipation, abdominal discomfort, decreased appetite. These typically peak during dose escalation and diminish at stable doses.
Less Common: Headache, dizziness, fatigue, injection site reactions. Rare but Serious: Pancreatitis (stop medication, seek emergency care), gallbladder issues, hypoglycemia (especially with insulin/sulfonylureas).
Management Tips: Eat smaller, more frequent meals. Avoid high-fat and spicy foods initially. Stay hydrated. Take medication in the evening. Report persistent symptoms to your doctor — dose adjustment often resolves issues.
Contraindications: Personal/family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia type 2 (MEN2), pregnancy, severe gastroparesis.
The rise of GLP-1 medications has led to a concerning trend: people obtaining these prescription drugs without proper medical supervision. This is dangerous and potentially life-threatening.
Why you need a doctor: Semaglutide requires careful dose titration (starting at 0.25mg and gradually increasing). Certain conditions like MTC, pancreatitis, and severe kidney disease are absolute contraindications. Drug interactions must be evaluated. Regular monitoring of blood glucose, kidney function, and thyroid markers is essential.
At India Fat to Fit, Dr. Akhileshwar Reddy (MBBS, MD Community Medicine) personally reviews every patient profile, checks for contraindications, and creates individualized treatment plans. Monthly follow-ups ensure safe dose adjustments and early detection of any adverse effects.
Our platform is fully NMC compliant, follows ICMR guidelines, and operates under the Digital Personal Data Protection Act 2023 for your privacy and security.
Adults with BMI ≥25 (Indian standard) or BMI ≥23 with at least one weight-related comorbidity (T2DM, hypertension, dyslipidemia, PCOS, sleep apnea). You must not have contraindications like MTC, MEN2, or active pancreatitis.
The fee covers a comprehensive review of your health assessment by Dr. Akhileshwar Reddy, a personalized weight loss plan, Indian diet plan, and medication prescription. Program and medication costs are separate.
We deliver pan-India via temperature-controlled courier. Semaglutide is a once-weekly injection pen that requires refrigeration. Delivery takes 3-5 business days depending on your location.
Most common: mild nausea (20%), diarrhea, constipation. These usually resolve within 2-4 weeks. Serious side effects are rare. Your doctor monitors you monthly and adjusts doses as needed.
STRICTLY NO REFUND. All payments — consultation fees, program fees, and medication costs — are final and non-refundable. Please review all details carefully before payment.
Semaglutide was originally developed for Type 2 Diabetes (as Ozempic). The STEP 2 trial specifically studied T2DM patients. However, dose adjustments may be needed for existing diabetes medications. Your doctor will coordinate this.
We prescribe FDA/CDSCO-approved semaglutide brands available in India. The specific brand depends on availability and your doctor's recommendation. All are bioequivalent.
Clinical trials show average 15-17% body weight loss over 68 weeks. Individual results vary based on adherence, diet, activity, and starting weight. Most patients see significant results by week 12.
In most cases, yes. Your doctor will review all current medications for interactions. Some diabetes medications may need adjustment. Never stop any medication without medical advice.
You'll have a comprehensive maintenance plan. Some patients transition to lower doses for maintenance; others may safely discontinue. Your doctor will guide the transition to prevent weight regain.
Yes. India Fat to Fit is a telehealth platform. Your initial assessment is done via our online form, and the doctor reviews it remotely. Follow-ups are via WhatsApp/phone. No in-person visits required.
WhatsApp: +91-7801009912 (fastest response). Email: care@indiafattofit.com. We respond within 4-6 hours during business hours (Mon-Sat, 9 AM - 7 PM IST).
"I lost 18 kg in 6 months. The personalized South Indian diet plan made it so easy — I didn't feel like I was dieting at all."
"As a PCOS patient, weight loss was impossible until I started GLP-1 therapy. Dr. Reddy's approach changed my life."
"My HbA1c dropped from 8.2 to 6.5, and I lost 22 kg. The monthly check-ins kept me accountable."
"The WhatsApp support is incredible. Anytime I had a side effect concern, I got a response within hours."
Results may vary. Individual outcomes depend on adherence to prescribed treatment, diet, and lifestyle modifications.